Pathologic Complete Response to Neoadjuvant Therapy in Patients with Pancreatic Ductal Adenocarcinoma Is Associated with Better Prognosis

In patients with pancreatic ductal adenocarcinoma (PDA) who received neoadjuvant therapy and pancreatectomy, pathologic complete response (pCR) is rarely observed and the prognostic significance of pCR is not clear. In this study, we reported 11 patients with pCR (2.5%) from 442 patients with PDA wh...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhao, Qing, Rashid, Asif, Gong, Yun, Katz, Matthew H., Lee, Jeffrey E., Wolf, Robert, Balachandran, Aparna, Varadhachary, Gauri R., Pisters, Peter W, Wang, Hua, Gomez, Henry F., Abbruzzese, James L., Fleming, Jason B., Wang, Huamin
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832988/
https://ncbi.nlm.nih.gov/pubmed/22050964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.anndiagpath.2011.08.005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky